contribute to the p53-mediated stimulation of Py DNA replication.
The p53 gene is the most frequently mutated gene ever found in human cancers and has been established as a tumor suppressor gene (30, 36) . In vitro transformation assays have revealed that wild-type p53 inhibits cell transformation induced by activated oncogenes (16) . Inactivation of the p53 gene plays a critical role in malignant transformation, probably by allowing cells to escape from normal growth control. Previous studies have demonstrated that wild-type p53 can mediate direct growth arrest of proliferating cells at the G1-S boundary (11, 39) . On the other hand, antibody microinjection experiments have indicated that wild-type p53 can also positively regulate cell proliferation (40) in apparent contradiction to later studies.
Although the precise molecular mechanism of the antiproliferative effect of p53 still remains unknown, one hypothesis has come from the fact that p53 possesses characteristics of a transcription factor (18, 47) . Like other transcriptional activators, p53 appears to have a modular domain structure; it contains a sequence-specific DNA-binding domain in the central portion of the molecule and a transcriptional activation domain within the N-terminal region (26, 46) . It has been shown that wild-type p53 activates transcription from various promoters in a sequence-dependent manner (17, 21, 35, 65) . Therefore, one can envisage that it may stimulate the expression of downstream genes that negatively control cell proliferation (61) . On the other hand, since overexpression of p53 is known to repress a variety of promoters which do not contain the p53 binding site (23, 38, 50, 56) , shutdown of the expression of a particular class of genes by increased levels of p53 could be the mechanism by which p53-mediated G, arrest occurs (38) .
Accumulating evidence suggests that p53 may also be directly involved in the regulation of DNA replication. For example, murine (5, 62) and human (20) wild-type p53 inhibits the simian virus 40 (SV40) replication in vivo (5) and in vitro (20, 62) . Murine and human wild-type p53, but not mutant forms, binds to the SV40 large T (LT) antigen, which acts as a helicase and also binds the cellular DNA polymerase a (22) . Wild-type p53 inhibits the initiation and propagation of SV40 DNA replication, most likely by preventing DNA unwinding by the LT antigen helicase (62) . p53 was also found to relocate to the same sites as known DNA replication proteins in herpesvirus-infected cells (63) , indicating that p53 may interact directly with components of the DNA replication machinery. In support of this observation, purified p53 protein has recently been shown to bind a cellular replication factor A (RPA) in vitro (13, 28, 37) . Moreover, it is worth noting that p53 binding sequences have been observed in various potential replication origins, such as the SV40 replication origin (2) and a putative replication origin of the ribosomal gene cluster (34) .
On the basis of these observations suggesting the involvement of p53 in DNA replication, it is tempting to speculate that p53 functions not only as a transcriptional regulator but also as a regulator of DNA replication. Polyomavirus (Py) DNA replication requires an enhancer (9, 10) . Therefore, the Py DNA replication system is ideal for studying the potential effects of transcription factors on DNA replication. Many transcription factors, including AP-1 (24, 44) , yeast GALA (3, 4, 24) , herpesvirus VP16 (3, 4, 24) , and Rel/NF-KB family (32) , are known to stimulate Py DNA replication by means of their respective binding sites inserted into the late side of the Py replication origin in place of enhancer. We tested whether wild-type p53 would directly activate Py DNA replication through its binding site. The Py DNA replication system has an additional advantage over the SV40 replication system. Unlike SV40 LT antigen, Py LT antigen has been shown not to bind wild-type p53 by immunoprecipitation technique (62) . There- fore, we can see whether wild-type p53 has any effect on Py DNA replication through the DNA binding without having the complication of the complex formation with LT antigen.
In this communication, we show that wild-type p53, but not mutant forms of p53, stimulates not only transcription but also Py DNA replication through the DNA-binding site. The results further indicate that the regions of the p53 molecule responsible for the two activities are, at least in part, separable. 
MATERIALS AND METHODS
Cell culture and transfection. The (10)1 cell line is a spontaneously immortalized BALB/c murine embryo fibroblast cell line (27) . Both F9 embryonal carcinoma cells and (10)1 cells were grown in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum.
Transfection experiments were performed by a modification of the Chen-Okayama calcium phosphate procedure (6) . For each dish, the total amount of the transfected DNA was adjusted to 20 pLg (10-cm dish) or to 10 p.g (6-cm dish) by the addition of pEF-BOS backbone vector. All transfection experiments were repeated independently at least twice.
Plasmids. All reporter plasmids were derivatives of pPyOICAT (44) . Three different double-stranded oligonucleotides representing the wild-type and mutant forms of the p53 binding sites, p53R, p53H, and p53M (see Fig. 1B ), were chemically synthesized and inserted into the pPyOICAT cleaved with Hindlll and BglII. A mutant form of Py enhancer, F9-5000, being functional in F9 cells (60) , was inserted into the same plasmids to make pPy(F9-5000)OICAT. pPy(p53H)Aori CAT has a deletion of a 43-bp fragment between the BamHIBglII and ApaI sites of pPy(p53H)OICAT. The deleted fragment contains the A/T-rich domain of the Py origin sequence.
The plasmid designated pPyOICAT in this paper is identical to pPyOICAT described by Murakami et al. (45) except for the deletion of the HindIIl-BglII fragment.
Plasmid vectors for expression of various p53 proteins and Py LT antigen were constructed with pEF-BOS vector (43) after the deletion of the SV40 replication origin by HindlIl digestion and self-ligation. The pEF-BOS vector (without SV40 ori) was digested by XbaI and blunt ended by Klenow enzyme. The BglII-BamHI fragment of pLSVNc-9 (15) encoding murine wild-type p53 was blunt ended by Klenow enzyme and inserted into pEF-BOS vector as described above to make pEF-BOSp53Wild. The blunt-end-modified BglII-BamHI fragment of pSVp53cl7, encoding the murine mutant p53 originated from Meth A fibrosarcoma cells (15) , was inserted into pEF-BOS vector to make pEF-BOSpS3MethA. The XhoISacII fragment of pLSVNc-9 was replaced by the XhoI-SacII fragment of MSVKH215, which is an artificial mutant made by linker insertion (19) , to make pLSVKH215. The blunt-endmodified BglII-BamHI fragment of pLSVKH215 was inserted into pEF-BOS vector to make pEF-BOSp53KH215.
pEF-BOSpS3Wild was digested by EcoRV and self-ligated to make pEF-BOSpS3AEE. To make pEF-BOSp53AES, pEFBOSp53LAEE was digested by Sacl and blunt ended by T4 DNA polymerase, and then it was digested by HindlIl to prepare the SacI(blunt)-HindIII vector (containing codons 67 to 390). Next, the HindIII-EcoRV fragment of pEFBOSp53zAEE, which contains the promoter and translation initiation site (codons 1 to 10), was subcloned to the SacI(blunt)-HindIII vector as described above. To make pEFBOSp53/NN, pEF-BOSpS3Wild was digested by NcoI To make the C-terminally truncated mutants, the SacII site (at codon 330) was modified by mung bean nuclease and religation. As a result, 2-bp deletions (GC) were generated. The protein produced by this plasmid is thus truncated after aa 360 with a 1-aa addition at codon 361 (GCG; alanine), because codon 362 is converted to a termination codon (TAA).
All the amino acid numbers of p53 protein are described according to Finlay et al. (19) (34) , and the p53H fragment has substitutions of 11 bp compared with p53R in order to perfectly match the highaffinity p53 binding sequence reported previously (25) .
To examine the effect of both endogenous and exogenously expressed various murine p53 proteins ( Fig. 2A) (44) . The thin arrow indicates the start point of Py early mRNA. ori, Py replication origin. (B) Inserted synthetic double-stranded oligonucleotides containing the p53 recognition sequences. The pS3R fragment has three tandem copies of the p53 binding consensus PuPuPuC(A/T)(A/T)GPyPyPy (14) with the exception of 3 bp (underlined). The p53M fragment has mutations of 9 bp (lowercase letters written near p53R sequence). The p53H fragment has substitutions of 11 bp (boldface letters) compared with p53R. RGC, ribosomal gene cluster.
ences around the PAb421 binding epitope between the two forms of p53. The M mutant and KH mutant generated no specific band (lanes 6 and 7), indicating that both p53 mutants lost the DNA-binding activity as described previously (33) . When p53R was used as a probe, the intensities of the shifted bands were much lower than those shown in Fig. 2B (data not shown), reproducing the data that p53H binds p53 more efficiently than does pS3R (25) . To confirm that both wild-type and mutant p53 proteins were present in the transfected cells at comparable levels, immunoprecipitation assays were performed after transfection into (10)1 cells. As shown in Fig. 2C Fig. 1A were transfected into F9 cells. As shown in Fig. 3A , pPy(pS3R)OI CAT showed a quite high level of CAT gene expression (lane 2) as previously reported (49) . pPy(p53H)OICAT showed a CAT activity even higher than that of pPy(p53R)OICAT (lane 3) , indicating that the levels of transactivation appeared to correlate with the binding affinities of p53 for the inserted sequences. pPy(p53M)OICAT showed only the basal-level CAT activity as did pPyOICAT, the reporter plasmid without any p53 binding site. The CAT activities of pPy(p53R)OICAT and pPy(p53H)OICAT were much higher than that of pPy(F9-5000)OICAT (lane 5).
Next, we transfected these five reporter plasmids into (10)1 cells. As shown in Fig. 3B , pPy(p53R)OICAT, pPy(p53H)OI CAT, and pPy(p53M)OICAT showed only the basal-level CAT activity as did pPyOICAT. pPy(F9-5000)OICAT showed a CAT activity stimulated by endogenous factors which would bind to the F9-5000 enhancer (lane 5), as was the case with F9 cells.
Then, we cotransfected wild-type and mutant p53 expression plasmids with various reporter plasmids into (10)1 cells. As can be seen in Fig. 4 examined whether p53 could also stimulate replication similarly, by using the very same reporter plasmids as for the CAT assay. Py chromosome replication relies entirely on the host replication machinery with the exception of a single viral protein, LT antigen. To supply LT antigen for replication assay in F9 and (10)1 cells, we cotransfected pEF-BOS LT, an expression plasmid of Py LT antigen.
Various reporter plasmids and LT antigen expression plasmid were cotransfected into F9 cells to see the effect of endogenous wild-type p53 on Py DNA replication. As can be seen in Fig. 5A , pPy(F9-5000)OICAT replicated quite well in F9 cells (lane 5) as reported earlier (44) . pPy(p53R)OICAT also replicated, but the level was much lower than that of pPy(F9-5000)OICAT (lane 2), in contrast to the results of the CAT assay shown in Fig. 3A . pPy(p53H)OICAT replicated much more efficiently than pPy(p53R)OICAT (compare lanes 2 and 3), presumably reflecting the binding preference of p53 for these two sequences. pPy(p53M)OICAT showed only the basal level of replication activity comparable to that of pPyOICAT, indicating that the replication activities were sequence dependent. These results suggest that endogenous wild-type p53 in F9 cells stimulates Py replication by means of the same DNA element as the one used for stimulation of transcription.
We performed similar experiments with (10)1 cells. Unlike the results obtained from F9 cells, pPy(p53R)OICAT, pPy(p53H)OICAT, and pPy(p53M)OICAT showed only the basal-level replication activity like that of pPyOICAT as expected (Fig. SB) replication. Next, we examined the effects of wild-type and mutant p53 on Py DNA replication with (10)1 cells. As shown in Fig. 6A , wild-type p53 strongly activated pPy(p53H)OICAT replication (lane 6). In contrast to wild-type p53, both M and KH mutants failed to activate the same reporter (lanes 7 and 8). Replication of pPy(pS3R)OICAT was also stimulated by wild-type p53 (lane 2), but to a much lesser degree compared with pPy(p53H)OICAT. Once again, the replication activities of these two reporter plasmids correlated well with the binding affinities of p53 for the inserted sequences. Curiously, the replication of pPy(pS3M)OICAT was strongly repressed by wild-type p53 but not by mutant p53. These results indicate that the stimulation of Py DNA replication by wild-type p53 is dependent on the p53 binding site in the reporter plasmid. This stimulation of Py replication by wild-type p53 completely depended on the Py origin sequence of the reporter plasmids (Fig. 6B, lanes 1 through 4) and LT antigen expression (lanes 5 through 8).
The inhibition of replication of pPy(p53M)OICAT by wildtype p53 can be interpreted in the following way. Wild-type p53 is known to down-regulate transcription from various promoters (23, 56) (see also Fig. 4, lane 14) . We observed that the EF-la-promoter, which drives Py LT antigen expression plasmid, was also repressed by wild-type p53 (data not shown). Since Py replication completely depends on LT antigen expression (Fig. 6B) , down-regulation of the pPy(pS3M)OICAT replication activity must be at least partly due to a reduction of LT antigen expression. To examine whether the level of LT antigen expression is indeed affected by wild-type p53, we cotransfected pEF-BOS LT with various p53 expression plasmids, and the amounts of LT antigen were examined by immunoprecipitation. As expected, wild-type p53 was found to reduce the expression level of LT antigen quite significantly (down to about 10% of control) ( Fig. 6C; compare lanes 2 and  3) . These results strongly suggest that the levels of stimulation of Py DNA replication by wild-type p53 shown in Fig. 6A , lanes 2 and 6, are significantly underrepresented. A repression of replication by wild-type p53 was observed in the case of pPy(F9-5000)OICAT (Fig. 6A, lane 14) and pPyOICAT (data not shown).
The acidic transactivation domain is important but dispensable for stimulating Py DNA replication. To determine whether the acidic transactivation domain is responsible for stimulating Py DNA replication, we made a series of Nterminal deletion mutants of wild-type p53 (Fig. 7A) .
To examine whether these deletion mutants have sequencespecific DNA-binding activities, EMSA was performed with labeled pS3H probe and WCE from (10)1 cells transfected with the expression plasmids encoding the deletion mutants. As shown in Fig. 7B, pS3AEE and pS3AES displayed moreintense and faster-migrating shifted bands than wild-type p53 in EMSA (compare lanes 3, 4, and 5). pS3ANN also displayed a shifted band (lane 6). These truncated proteins reacted with PAb421 (lanes 11, 12, and 13), indicating that they are genuine p53 derivatives. On the other hand, pS3A153, which lacked the evolutionarily conserved region II (53), did not show any shifted band, although its expression was confirmed by immunoprecipitation (Fig. 7C, lane 7) . These results suggest that the evolutionarily conserved region II is indispensable for the sequence-specific DNA binding. CAT assay revealed that pS3AEE was only 8% as active as wild-type p53 in stimulating transcription from pPy(pS3H)OICAT (Fig. 7D, lanes 2 and 3) . p53AES, pS3ANN, and pS3AlS153 did not show any ability to stimulate transcription at the detectable levels (lanes 4, 5, and 6). Concurrent with our studies, similar results have been observed by others (59) with an N-terminal deletion mutant of human p53. Interestingly, the deletion of the transactivation domain eliminated or significantly reduced not only the sequence-dependent transactivation but also the sequence-independent transrepression (data not shown).
We then compared the replication-stimulating activity of the N-terminal deletion mutants with that of the wild-type p53. As shown in Fig. 8A Fig. 7B , we deleted the C-terminal 60 aa of wild-type p53 and p53ANN. As a result, p53ANN-tr contains the four evolutionarily conserved regions (II, III, IV, and V) and the major nuclear localization signal as well (52) . By EMSA with p53H probe, p53ANN-tr displayed a specific shifted band (Fig. 9B, lane 4) , and the band was supershifted with PAb246, the central portion-specific antibody (lane 8).
Although there was no visible shifted band with p53W-tr (lane 2), we could see shifted bands when PAb242 (64) , the Nterminal specific antibody, was added (lane 10). These results strongly suggest that p53W-tr and p53ANN-tr retain the intrinsic sequence-specific DNA-binding activities, although it has been demonstrated that the C-terminal deletion mutants are likely to be monomeric and do not exhibit measurable DNA binding in vitro (51, 57) . We confirmed the expression of pS3W-tr and p53ANN-tr by immunoprecipitation with PAb246 (Fig. 9C) . However, for unknown reasons, we could not efficiently immunoprecipitate p53ANN by PAb246, although we had already confirmed the expression of p53ANN in Fig. 7C with PAb421. CAT assay revealed that p53W-tr fully retained as much transcription-stimulating activity as did wild-type p53 (Fig. 9D, lane 3) , supporting the previously reported data that the C-terminal oligomerization domain is dispensable for stimulating transcription (51, 57) . Interestingly, p53W-tr lost 5 and 12), p53ANN (ANN, lanes 6 and 13), p53A153 (A153, lanes 7 and 14) , or backbone vector (B, lanes 2 and 9) were assayed for binding to the p53H probes. the sequence-independent transrepression activity (data not sion of LT antigen was strongly repressed by wild-type p53 shown).
( Fig. lOB, lane 3) but it was affected by the C-terminally Then, we proceeded to the replication assay with these truncated mutants to much lesser degrees (lanes 4 and 6). mutants. As shown in Fig. 1OA , deletion of the C-terminal Considering the expression levels of LT antigen, p53ANN-tr oligomerization domain significantly reduced the ability to must have a significantly lesser ability to stimulate Py DNA stimulate Py DNA replication, although the same deletion replication than wild-type p53. These results suggest that, in hardly impaired the transcriptional activity. Again, the expresaddition to the N-terminal acidic region, the C-terminal basic (3, 4) . Moreover, if we further delete the C-terminal region, replication-stimulating activity is further impaired, although the C-terminal deletion hardly impairs the transcriptional activation. ANN-tr containing the minimum region for DNA binding is strongly impaired in stimulating Py DNA replication. We conclude that both the N-terminal transactivation domain and the C-terminal oligomerization domain significantly contribute to the activity.
Several interpretations concerning the mechanism by which p53 stimulates Py DNA replication can be made from these results. One possibility is that wild-type p53 binds near the Py replication origin to negate the repressive effects of core histones. The intact N-terminal and C-terminal regions of p53, in addition to the sequence-specific DNA-binding domain, might be required to prevent chromatin assembly and to facilitate formation of the replication initiation complex at the origin. This notion is supported by the studies of SV40 DNA replication in vitro with NF-1/CTF (7) and GAL4-VP16 (8) , which demonstrate that the transcriptional activation domains are required to antagonize the inhibitory effects of histones.
Alternatively, wild-type p53 could make specific proteinprotein contacts with replication factors. The mechanism of transcriptional activation may be the precedent which highlights the importance of protein-protein interaction. The acidic activation domain of p53, like that of VP16, has been shown to interact directly with the TATA box-binding protein, TBP (50, 58) , a subunit of the RNA polymerase II general initiation factor TFIID. An interaction with TBP may be a general feature of the transcriptional activation mechanism (58) .
Two groups have recently reported that the acidic transcriptional activation domains of VP16, GAL4, and p53 can bind to RPA in vitro (28, 37) . RPA is a trimeric single-stranded DNA-binding protein that is required for initiation of DNA replication in vitro in a number of systems (54) . Mutations in the VP16 transactivation domain that compromise Py DNA replication reduce the binding to RPA (28) late in vitro replication of bovine papillomavirus type 1 DNA (37), and this cell-free system has also suggested the importance of p53-RPA interaction. The fact that the transcriptional activation domain of p53 is dispensable for stimulating Py replication raises the possibility that the RPA-p53 interaction has little, if anything, to do with Py replication. However, more recently, in addition to the N-terminal acidic domain, the C-terminal region of human p53 has also been shown to interact with RPA in vitro (13) . Those data predict that ANN-tr, which lacks both the N-and C-terminal regions, cannot interact with RPA. The correlation between the RPA-p53 interaction and the stimulation of Py replication is noteworthy. Therefore, although we must consider many other possibilities, one of the candidates for the cellular target proteins of p53 in the process of stimulating Py DNA replication would be RPA. We can envisage the following scenario. When stimulating Py DNA replication, with exogenously expressed LT antigen, wild-type p53 may facilitate formation of a ternary complex between RPA, DNA, and LT antigen at the Py origin, which may subsequently assemble DNA polymerase a-primase complex. The fact that ANN-tr retains some replication-stimulating activities suggests that ANN-tr has another functional domain interacting with replication-related proteins, or that DNA binding itself may contribute to the stimulation of replication by negating the repressive effects of core histones.
Our results appear to contradict the previous reports that murine and human p53 inhibit SV40 DNA replication in vitro (20, 62) . This apparent discrepancy could be mainly due to the interaction between p53 and SV40 LT antigen. The SV40 in vitro replication system requires a molar ratio of p53-LT antigen of at least 1:1 before significant inhibition can be observed (20) . Under such conditions, SV40 LT antigen may be functionally eliminated by p53 and may become insufficient to sustain SV40 replication. In our Py replication system, we supply sufficient amounts of Py LT antigen, which does not bind p53.
If the interaction of p53 with RPA or other cellular protein contributes to stimulating Py DNA replication, it is tempting to speculate that wild-type p53 also regulates cellular replication in a similar manner. Although it would not agree with the known antiproliferative effect of wild-type p53, the striking contrast between wild-type and oncogenic mutant p53 protein in our system is noteworthy. If the sequence-specific DNAbinding activity of p53 is required to regulate cellular replication, either positively or negatively, oncogenic mutations are expected to impair the ability not only to regulate transcription but also to regulate replication. Recently, an N-terminal deletion mutant has been shown to have some transformation suppression activity, indicating that transcriptional regulation is dispensable for tumor suppression (59) . Therefore, the function of regulating replication might be one of the candidates for at least part of the basis of tumor suppression. Further studies, especially in vitro replication studies, will be needed to determine the precise mechanism of stimulation of Py DNA replication, and to clarify whether p53 also regulates cellular replication in a similar fashion.
